285 related articles for article (PubMed ID: 27883053)
1. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
Park Y; Lim S; Nam JW; Kim S
Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
[TBL] [Abstract][Full Text] [Related]
2. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
Kim M; Lee S; Lim S; Kim S
PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
[TBL] [Abstract][Full Text] [Related]
3. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
Song D; Wang X
J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
[TBL] [Abstract][Full Text] [Related]
4. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
5. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
Ai H; Song D; Wang X
Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
7. An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles.
Li M; Zhang Z; Li L; Wang X
Commun Biol; 2020 Sep; 3(1):505. PubMed ID: 32917965
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
[TBL] [Abstract][Full Text] [Related]
9. Single-cell DNA and RNA sequencing reveals the dynamics of intra-tumor heterogeneity in a colorectal cancer model.
Ono H; Arai Y; Furukawa E; Narushima D; Matsuura T; Nakamura H; Shiokawa D; Nagai M; Imai T; Mimori K; Okamoto K; Hippo Y; Shibata T; Kato M
BMC Biol; 2021 Sep; 19(1):207. PubMed ID: 34548081
[TBL] [Abstract][Full Text] [Related]
10. Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer.
Zhao W; Zhu B; Hutchinson A; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Wang D; Shi J; Landi MT
J Natl Cancer Inst; 2022 Feb; 114(2):280-289. PubMed ID: 34402912
[TBL] [Abstract][Full Text] [Related]
11. FDM: a graph-based statistical method to detect differential transcription using RNA-seq data.
Singh D; Orellana CF; Hu Y; Jones CD; Liu Y; Chiang DY; Liu J; Prins JF
Bioinformatics; 2011 Oct; 27(19):2633-40. PubMed ID: 21824971
[TBL] [Abstract][Full Text] [Related]
12. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
13. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
14. Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.
Niida A; Nagayama S; Miyano S; Mimori K
Cancer Sci; 2018 Apr; 109(4):884-892. PubMed ID: 29352488
[TBL] [Abstract][Full Text] [Related]
15. Joint analysis of single-cell and bulk tissue sequencing data to infer intratumor heterogeneity.
Sun W; Jin C; Gelfond JA; Chen MH; Ibrahim JG
Biometrics; 2020 Sep; 76(3):983-994. PubMed ID: 31813161
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Saeki S; Kumegawa K; Takahashi Y; Yang L; Osako T; Yasen M; Otsuji K; Miyata K; Yamakawa K; Suzuka J; Sakimoto Y; Ozaki Y; Takano T; Sano T; Noda T; Ohno S; Yao R; Ueno T; Maruyama R
Breast Cancer Res; 2023 Feb; 25(1):21. PubMed ID: 36810117
[TBL] [Abstract][Full Text] [Related]
17. Cell Heterogeneity Analysis in Single-Cell RNA-seq Data Using Mixture Exponential Graph and Markov Random Field Model.
Wang Y; Tian X; Ai D
Biomed Res Int; 2021; 2021():9919080. PubMed ID: 34095314
[TBL] [Abstract][Full Text] [Related]
18. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
Nguyen PHD; Ma S; Phua CZJ; Kaya NA; Lai HLH; Lim CJ; Lim JQ; Wasser M; Lai L; Tam WL; Lim TKH; Wan WK; Loh T; Leow WQ; Pang YH; Chan CY; Lee SY; Cheow PC; Toh HC; Ginhoux F; Iyer S; Kow AWC; Young Dan Y; Chung A; Bonney GK; Goh BKP; Albani S; Chow PKH; Zhai W; Chew V
Nat Commun; 2021 Jan; 12(1):227. PubMed ID: 33431814
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
Kikutake C; Yoshihara M; Sato T; Saito D; Suyama M
Oncotarget; 2018 Dec; 9(102):37689-37699. PubMed ID: 30701024
[TBL] [Abstract][Full Text] [Related]
20. Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
Sung JY; Shin HT; Sohn KA; Shin SY; Park WY; Joung JG
PLoS One; 2019; 14(7):e0219682. PubMed ID: 31310640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
